Conversion to the COBAS AmpliPrep/COBAS TaqMan CMV Test for management of CMV disease in transplant recipients

Bobbi S. Pritt, Jeffrey J. Germer, Eric Gomez-Urena, Callie J. Bishop, Jayawant N. Mandrekar, Cole L. Irish, Joseph D.C. Yao

Research output: Contribution to journalArticle

11 Scopus citations

Abstract

Testing of clinical plasma specimens by the COBAS AmpliPrep/COBAS TaqMan CMV Test (CAP/CTM CMV), COBAS AMPLICOR CMV MONITOR Test (CAM CMV), and a laboratory-developed assay using analyte-specific reagents (LC CMV) demonstrated substantial result bias for CAP/CTM CMV versus CAM CMV (. r = 0.436) and CAP/CTM CMV versus LC CMV (. r = 0.773).

Original languageEnglish (US)
Pages (from-to)440-442
Number of pages3
JournalDiagnostic Microbiology and Infectious Disease
Volume75
Issue number4
DOIs
StatePublished - Apr 1 2013

Keywords

  • CMV
  • Cytomegalovirus
  • Quantitative PCR
  • Real-time PCR
  • Viral load

ASJC Scopus subject areas

  • Microbiology (medical)
  • Infectious Diseases

Fingerprint Dive into the research topics of 'Conversion to the COBAS AmpliPrep/COBAS TaqMan CMV Test for management of CMV disease in transplant recipients'. Together they form a unique fingerprint.

  • Cite this